Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The poly(A) tail of influenza virus mRNAs is synthesized by the viral RNA polymerase by reiterative copying of a U5-7 sequence near the 5' end of the viral RNA (vRNA) template. We have engineered a vRNA molecule by replacing its viral U6 poly(A) site with a negative-sense eukaryotic polyadenylation signal. The vRNA was transcribed by the viral RNA polymerase and the transcription product was processed by the cellular 3' end processing machinery in vivo. According to the current model, 3' end processing of eukaryotic pre-mRNAs is coupled to cellular RNA polymerase II (pol II) transcription; thus only RNAs synthesized by pol III are believed to be polyadenylated efficiently. Our results show that the cellular polyadenylation machinery is nevertheless able to recognize and process RNA transcripts that are not synthesized by pol II, indicating that synthesis by pol II is not an absolute requirement for 3' end processing in vivo.

Original publication

DOI

10.1093/embo-reports/kvd111

Type

Journal article

Journal

EMBO Rep

Publication Date

12/2000

Volume

1

Pages

513 - 518

Keywords

Base Sequence, Cell Line, Cloning, Molecular, Humans, Influenza, Human, Molecular Sequence Data, Mutagenesis, Neuraminidase, Plasmids, Poly A, RNA Polymerase II, RNA, Messenger, RNA, Viral, Reverse Transcriptase Polymerase Chain Reaction, Single-Strand Specific DNA and RNA Endonucleases, Time Factors, Transcription, Genetic, Transfection